After the Gambia, Nigeria, Liberia issue alerts over Maiden Pharma's syrups

Nigeria has reportedly circulated the alert across all professional bodies, health care providers and supply chain associates

Nigeria and Liberia have issued alerts over cough syrups manufactured by Haryana-based Maiden Pharmaceuticals following the death of 69 children in the Gambia. According to the World Health Organization (WHO), four syrups manufactured by the company have been linked with acute kidney injuries, as reported by Mint. 

Nigeria's National Agency for Food and Drug Administration Agency Control (NAFDAC) on Thursday issued an alert on "substandard paediatric cough syrups circulating in the Gambia", the report said. 

Liberian health minister Wilhelmina S Jallah, in a separate alert, told health teams to "further inform all health service delivery points (hospitals, health centres, clinics